Psoralen Derivatives as Inhibitors of Mycobacterium tuberculosis Proteasome

Protein degradation is a fundamental process in all living organisms. An important part of this system is a multisubunit, barrel-shaped Protease complex called the Proteasome. This Enzyme is directly responsible for the proteolysis of ubiquitin- or pup-tagged proteins to smaller Peptides. In this study, we present a series of 92 psoralen derivatives, of which 15 displayed inhibitory potency against the Mycobacterium tuberculosis Proteasome in low micromolar concentrations. The best inhibitors, i.e., 8, 11, 13 and 15, exhibited a mixed type of inhibition and overall good inhibitory potency in biochemical assays. N-(cyanomethyl)acetamide 8 (K_i = 5.6 µM) and carboxaldehyde-based derivative 15 (K_i = 14.9 µM) were shown to be reversible inhibitors of the Enzyme. On the other hand, pyrrolidine-2,5-dione esters 11 and 13 irreversibly inhibited the Enzyme with K_i values of 4.2 µM and 1.1 µM, respectively. In addition, we showed that an established immunoproteasome inhibitor, PR-957, is a noncompetitive irreversible inhibitor of the mycobacterial Proteasome (K_i = 5.2 ± 1.9 µM, k_inact/K_i = 96 ± 41 M^-1·s^-1). These compounds represent interesting hit compounds for further optimization in the development of new drugs for the treatment of tuberculosis.